ArticleJournal for immunotherapy of cancer2025

AMPK agonism optimizes the in vivo activation and antileukemic efficacy of chimeric antigen receptor T cells.

Erica Braverman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.